Dementias Completed Phase 2 Trials for Memantine (DB01043)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00200538Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) PatientsTreatment